Trial Manager - Oncology Clinical Trials Office (OCTO)
I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in June 2021 having previously worked in surgical trials for nearly 4 years. Prior to this I worked as a Trial Administrator in OCTO, and a Data Clerk at Warwick CTU.
I am currently working on the following trials:
TebeMRD - A Phase II Non-Randomized, Open-label, Multi-centre Study of the Safety and Efficacy of Tebentafusp in Melanoma with Molecular Relapsed Disease
OCTOVA - Randomised Phase II Trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum–resistant ovarian cancer
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): statistical analysis plan for a randomised controlled trial assessing the effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone.
Stokes JR. et al, (2021), Trials, 22
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): study protocol for a patient-blinded, randomised controlled superiority trial of liposomal bupivacaine.
Knight R. et al, (2019), Trials, 20